Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

HIV Infection

Free Subscription Articles published in Lancet Retrieve available abstracts of 77 articles: HTML format

Single Articles

November 2023
1. THE LANCET
   Preventing healers from becoming killers.
   Lancet. 2023;402:1805.
   PubMed    
   
   
   
2. NUNEZ I, Valdes-Ferrer SI
   Classifying necrotising mpox as an AIDS-defining condition - Authors' reply.
   Lancet. 2023;402:1752.
   PubMed    
   
   
   
3. MITJA O, Paredes R, Cabtree B, Orkin C, et al
   Classifying necrotising mpox as an AIDS-defining condition.
   Lancet. 2023;402:1751-1752.
   PubMed    
   
   
   
4. WONG M, Damon IK, Zucker J, Foote MMK, et al
   ART initiation for people living with HIV with severe mpox.
   Lancet. 2023;402:1750.
   PubMed    
   
   
   
5. KASPER T, Yamey G, Dwyer S, McDade KK, et al
   Rethinking how development assistance for health can catalyse progress on primary health care.
   Lancet. 2023 Nov 10:S0140-6736(23)01813-5. doi: 10.1016/S0140-6736(23)01813.
   PubMed     Abstract available
   
   
   October 2023
6. MEMISH ZA, Blumberg L, Al-Maani AS, Baru R, et al
   Moving cholera vaccines ahead of the epidemic curve.
   Lancet. 2023 Oct 17:S0140-6736(23)02244-4. doi: 10.1016/S0140-6736(23)02244.
   PubMed    
   
   
   
7. KIVUYO S, Birungi J, Okebe J, Wang D, et al
   Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial.
   Lancet. 2023;402:1241-1250.
   PubMed     Abstract available
   
   
   
8. BALDEH M, Kizito S
   Call to action: HIV among adolescents in Sierra Leone.
   Lancet. 2023;402:1240.
   PubMed    
   
   
   
9. KISIGO GA, Peck RN
   Integrating HIV, hypertension, and diabetes primary care in Africa.
   Lancet. 2023;402:1211-1213.
   PubMed    
   
   
   September 2023
10. KAVANAGH MM, Wenham C, Massard da Fonseca E, Helfer LR, et al
    Increasing compliance with international pandemic law: international relations and new global health agreements.
    Lancet. 2023 Sep 4:S0140-6736(23)01527-1. doi: 10.1016/S0140-6736(23)01527.
    PubMed     Abstract available
    
    
    August 2023
11. ZHU DT, Friedman J, Bourgois P, Montero F, et al
    The emerging fentanyl-xylazine syndemic in the USA: challenges and future directions.
    Lancet. 2023 Aug 24:S0140-6736(23)01686-0. doi: 10.1016/S0140-6736(23)01686.
    PubMed    
    
    
    
12. THE LANCET
    Ending the HIV pandemic: preparing for the future.
    Lancet. 2023;402:585.
    PubMed    
    
    
    
13. MARTIN CA, Medisauskaite A, Gogoi M, Teece L, et al
    Discrimination, feeling undervalued, and health-care workforce attrition: an analysis from the UK-REACH study.
    Lancet. 2023 Aug 18:S0140-6736(23)01365-X. doi: 10.1016/S0140-6736(23)01365.
    PubMed    
    
    
    
14. 
    Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
    Lancet. 2023 Aug 3:S0140-6736(23)01088-7. doi: 10.1016/S0140-6736(23)01088.
    PubMed     Abstract available
    
    
    July 2023
15. BROYLES LN, Luo R, Boeras D, Vojnov L, et al
    The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review.
    Lancet. 2023 Jul 21:S0140-6736(23)00877-2. doi: 10.1016/S0140-6736(23)00877.
    PubMed     Abstract available
    
    
    
16. BEKKER LG, Smith P, Ntusi NAB
    HIV is sexually untransmittable when viral load is undetectable.
    Lancet. 2023 Jul 21:S0140-6736(23)01519-2. doi: 10.1016/S0140-6736(23)01519.
    PubMed    
    
    
    
17. SHARMA DC
    Ethnic conflict hampering health services in Manipur, India.
    Lancet. 2023;402:94.
    PubMed    
    
    
    June 2023
18. 
    The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    PubMed     Abstract available
    
    
    May 2023
19. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
    PubMed    
    
    
    
20. ZEGGAGH J, Ferraris O, Salmona M, Tarantola A, et al
    Second clinical episode of hMPX virus in a man having sex with men.
    Lancet. 2023;401:1610.
    PubMed    
    
    
    April 2023
21. O'SHEA J, Daskalakis D, Brooks JT
    The emergence of mpox as an HIV-related opportunistic infection.
    Lancet. 2023;401:1264.
    PubMed    
    
    
    
22. WEBSTER P
    PEPFAR at 20.
    Lancet. 2023;401:1145-1146.
    PubMed    
    
    
    
23. NKENGASONG J, Ratevosian J
    Legal and policy barriers for an effective HIV/AIDS response.
    Lancet. 2023 Apr 5:S0140-6736(23)00729-8. doi: 10.1016/S0140-6736(23)00729.
    PubMed    
    
    
    March 2023
24. NUNEZ I, Valdes-Ferrer SI
    Fulminant mpox as an AIDS-defining condition: useful or stigmatising?
    Lancet. 2023;401:881-884.
    PubMed    
    
    
    
25. WATTS G
    Bern-Thomas Nyang'wa: getting things done in TB and HIV.
    Lancet. 2023 Mar 17:S0140-6736(23)00576-7. doi: 10.1016/S0140-6736(23)00576.
    PubMed    
    
    
    
26. MADANITSA M, Barsosio HC, Minja DTR, Mtove G, et al
    Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlle
    Lancet. 2023 Mar 10:S0140-6736(22)02535-1. doi: 10.1016/S0140-6736(22)02535.
    PubMed     Abstract available
    
    
    February 2023
27. MITJA O, Alemany A, Marks M, Lezama Mora JI, et al
    Mpox in people with advanced HIV infection: a global case series.
    Lancet. 2023 Feb 20:S0140-6736(23)00273-8. doi: 10.1016/S0140-6736(23)00273.
    PubMed     Abstract available
    
    
    January 2023
28. KIRBY T, Thornber-Dunwell M
    10 years on-high-risk practices on the London gay scene.
    Lancet. 2023;401:94-95.
    PubMed    
    
    
    December 2022
29. BYANYIMA W, Lauterbach K, Kavanagh MM
    Community pandemic response: the importance of action led by communities and the public sector.
    Lancet. 2022 Dec 14:S0140-6736(22)02575-2. doi: 10.1016/S0140-6736(22)02575.
    PubMed    
    
    
    
30. SAMARASEKERA U
    Pakistan's growing HIV epidemic.
    Lancet. 2022;400:2031.
    PubMed    
    
    
    November 2022
31. THORNHILL JP, Palich R, Ghosn J, Walmsley S, et al
    Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.
    Lancet. 2022 Nov 17:S0140-6736(22)02187-0. doi: 10.1016/S0140-6736(22)02187.
    PubMed     Abstract available
    
    
    
32. GOODALL RL, Meredith SK, Nunn AJ, Bayissa A, et al
    Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
    Lancet. 2022 Nov 7. pii: S0140-6736(22)02078.
    PubMed     Abstract available
    
    
    
33. JACKSON S, Kabir Z, Comiskey C
    Divergence in pace of decline in tuberculosis rates among migrants versus non-migrants in Ireland from 2011 to 2020.
    Lancet. 2022;400 Suppl 1:S52.
    PubMed     Abstract available
    
    
    October 2022
34. MYERS B, Lombard CJ, Lund C, Joska JA, et al
    Comparing dedicated and designated approaches to integrating task-shared psychological interventions into chronic disease care in South Africa: a three-arm, cluster randomised, multicentre, open-label trial.
    Lancet. 2022;400:1321-1333.
    PubMed     Abstract available
    
    
    
35. PAN D, Sze S, Nazareth J, Martin CA, et al
    The monkeypox case definition in the UK is broad - Authors' reply.
    Lancet. 2022;400:1301-1302.
    PubMed    
    
    
    
36. KIRBY T
    Anthony Fauci: moving on.
    Lancet. 2022;400:1182-1183.
    PubMed    
    
    
    September 2022
37. LUO R, Fong Y, Boeras D, Jani I, et al
    The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
    Lancet. 2022;400:887-895.
    PubMed     Abstract available
    
    
    
38. TECHNAU KG, Mazanderani AH
    Point-of-care HIV diagnosis for infants: the outcomes we need to achieve.
    Lancet. 2022;400:864-865.
    PubMed    
    
    
    August 2022
39. THORNTON J
    Botswana's HIV/AIDS success.
    Lancet. 2022;400:480-481.
    PubMed    
    
    
    
40. TARIN-VICENTE EJ, Alemany A, Agud-Dios M, Ubals M, et al
    Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study.
    Lancet. 2022 Aug 8. pii: S0140-6736(22)01436.
    PubMed     Abstract available
    
    
    July 2022
41. MAYER KH, Phanuphak N, Mgodi N, Grinsztejn B, et al
    New HIV prevention approaches: promise, praxis, and pitfalls.
    Lancet. 2022;400:257-259.
    PubMed    
    
    
    
42. 
    Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    PubMed     Abstract available
    
    
    
43. BOOTH A
    New HIV law welcomed in Argentina.
    Lancet. 2022;400:149.
    PubMed    
    
    
    
44. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    PubMed    
    
    
    June 2022
45. CHARANI E, McKee M, Balasegaram M, Mendelson M, et al
    Global burden of antimicrobial resistance: essential pieces of a global puzzle.
    Lancet. 2022;399:2346-2347.
    PubMed    
    
    
    
46. PAN D, Sze S, Nazareth J, Martin CA, et al
    Monkeypox in the UK: arguments for a broader case definition.
    Lancet. 2022 Jun 15. pii: S0140-6736(22)01101.
    PubMed    
    
    
    May 2022
47. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    PubMed    
    
    
    
48. 
    Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 May 23. pii: S0140-6736(22)00532.
    PubMed     Abstract available
    
    
    
49. WATTS G
    Luc Antoine Montagnier.
    Lancet. 2022;399:1862.
    PubMed    
    
    
    April 2022
50. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    PubMed    
    
    
    
51. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    PubMed    
    
    
    
52. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    PubMed    
    
    
    
53. MUDZINGWA EK, Parker IK
    Long-acting injections for HIV prevention among women in sub-Saharan Africa.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00613.
    PubMed    
    
    
    
54. DELANY-MORETLWE S, Hughes JP, Bock P, Ouma SG, et al
    Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00538.
    PubMed     Abstract available
    
    
    March 2022
55. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    PubMed    
    
    
    
56. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    PubMed    
    
    
    
57. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    PubMed     Abstract available
    
    
    
58. 
    Progress in health among regions of Ethiopia, 1990-2019: a subnational country analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02868.
    PubMed     Abstract available
    
    
    
59. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    PubMed    
    
    
    February 2022
60. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    PubMed    
    
    
    
61. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    PubMed    
    
    
    
62. MINALGA B, Chung C, Davids JD, Martin A, et al
    Research on transgender people must benefit transgender people.
    Lancet. 2022;399:628.
    PubMed    
    
    
    
63. SIVA N
    Gilead and ViiV Healthcare reach settlement over HIV drug.
    Lancet. 2022;399:618.
    PubMed    
    
    
    
64. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    PubMed    
    
    
    
65. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    PubMed    
    
    
    
66. VAN DER MERWE LL, Cloete A, Skinner D
    How HIV advocacy can be used to ensure quality transgender health care: lessons from South Africa.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00177.
    PubMed    
    
    
    January 2022
67. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    PubMed     Abstract available
    
    
    
68. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    PubMed    
    
    
    December 2021
69. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.
    PubMed    
    
    
    
70. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
    PubMed    
    
    
    November 2021
71. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
    PubMed    
    
    
    
72. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.
    PubMed    
    
    
    
73. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    PubMed    
    
    
    
74. FALCARO M, Castanon A, Ndlela B, Checchi M, et al
    The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02178.
    PubMed     Abstract available
    
    
    October 2021
75. 
    Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2021;398:1593-1618.
    PubMed     Abstract available
    
    
    
76. ADEPOJU P
    Nkengasong tipped to lead PEPFAR.
    Lancet. 2021;398:e15.
    PubMed    
    
    
    July 2021
77. SAMARASEKERA U
    Etheldreda Nakimuli-Mpungu: innovator in mental health.
    Lancet. 2021;398:109.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.